Lillian Falese

Lillian Falese

Company: Spirovant Sciences

Job title: Associate Director - Bioanalytical Development


Immunogenicity Profile in Wild-Type Ferrets After Treatment With SP-101 & Doxorubicin: Inhalation Delivery of AAV Gene Therapy for the Treatment of Cystic Fibrosis 12:30 pm

Sharing the impact of inhalation delivery on the post-dose capsid neutralizing antibody (cell-based assay) profile Implementation of a post-dose capsid total antibody (IgG) response and the decision-making process leading to a screen and titer strategy Evaluation of ferret T-cell responses to the capsid and transgene measured via ELISPOT, the implications of measuring no or low…Read more

day: Day 1 Tacks 1 AM

© Copyright 2023 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.